Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States.
In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals, medical devices and food supplements are tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany.
Europe + North AmericaHeadcount
Lil-Dagover-Ring 7, 82031 Grünwald – Germany
|Date||Trading entity / Person||Association||Trade type||Volume|
|27.06.23||Feldmeier, Dr. Hans-Georg||Board||Buy||EUR 99,902.36|
|04.04.23||Dreibholz, Benjamin||Close relation||Buy||EUR 449.28|
|04.04.23||Dreibholz, Katharina||Close relation||Buy||EUR 449.04|
|03.04.23||Dreibholz, Christof||Board||Buy||EUR 49,024.00|
|13.01.23||NEON Equity AG||Close relation||Buy||EUR 16,897.00|
|11.01.23||Dreibholz, Christof||Board||Buy||EUR 49,638.00|
|17.10.22||Riedel, Oliver||Board||Buy||EUR 11,013.18|
|17.10.22||Riedel, Oliver||Board||Buy||EUR 8,650.00|
|17.10.22||Weidenmann, Ralph||Supervisory board||Buy||EUR 2,638.25|
|14.10.22||Feldmeier, Dr. Hans-Georg||Board||Buy||EUR 98,900.00|
Joh. Berenberg, Gossler & Co. KG
Stifel Europe Bank AGListed Stock Exchange
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.